Primary tumor characteristics and next-generation sequencing mutations as biomarkers for melanoma immunotherapy response.

This analysis demonstrates an association between lymphovascular invasion and immunotherapy response. Additionally, NGS mutation analysis demonstrated a potential association between NRAS mutations and immunotherapy response.